Basilea Pharmaceutica Rises Most in 11 Months on Speculation About Takeover Approaches

January 6, 2011 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Bloomberg -- Basilea Pharmaceutica AG rose the most in 11 months in Zurich trading after Helvea SA said the company’s low valuation, cash reserves and portfolio of anti- infectives make it an “imminent” takeover target.

Twitter
LinkedIn
Facebook
Email
Print

Mergers & acquisitions